Alveolar Ridge Preservation Following Tooth Extraction Using Advanced Platelet Rich Fibrin (A-PRF) Versus Platelet Rich Fibrin (PRF)

NCT04434703 — Not applicable, Unknown, 60 participants, Cairo University
ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Alveolar Ridge Preservation Following Tooth Extraction Using Advanced Platelet Rich Fibrin (A-PRF) Versus Platelet Rich Fibrin (PRF) A Randomized Clinical Trail :Comparative Study

RegistryNCT04434703
StatusUnknown
PhaseNot applicable
Study typeInterventional; randomized, parallel, masking: triple, prevention
Enrollment60 (Estimated)
SponsorCairo University (Other)
ConditionsAlveolar Bone Resorption
InterventionsPlatelet rich fibrin (PRF), Advanced platelet rich fibrin (A-PRF), blood clot (Procedure)
Datesstart 2020-11-01, primary completion 2021-07-01 (estimated), completion 2021-09-01 (estimated), first posted 2020-06-17, last updated 2021-01-29
Locations1 site in Egypt

Related Papers Related Patents Related Grants Related Experts
All trials for Alveolar Bone Resorption All trials of Platelet rich fibrin (PRF) All trials of Advanced platelet rich fibrin (A-PRF)

-Summary

the aim of this study is clinically and radiographically evaluate the use of advance platelet rich fibrin (A-PRF) versus platelet rich fibrin (PRF) in preservation of alveolar ridge following tooth extraction

Expand all sections  ·  Collapse all

+Detailed description

systemically healthy patients who have at least one non-restorable tooth in the upper inter-bicuspid region and are not seeking immediate or early implant treatment will be allocated in this study after performing nonsurgical periodontal therapy and preoperative periapical therapy to evaluate and improve the condition of the periodontal tissues.

Anesthesia will be given then flapless atraumatic extraction using periotomes followed by forceps after luxation. For all groups, the socket will be debrided using curette then

* group A, the socket will be filled with A.PRF
* group B the socket will be filled with PRF.
* group C no bio-additive will be added.
* Criss cross horizontal mattress suture will be applied to close the extraction wound.

PRF and A-PRF preparation :

10 ml of blood will be drawn from each patient by vein puncture of the antecubital vein.

* Plateletr ich fibrin (PRF) is 3000 rpm and 10 minutes without addition of anticoagulant
* Advanced platelet rich fibrin (A-PRF) is 1300 rpm and 8 minutes.

+Arms and interventions

ArmTypeInterventionsDescription
Platelet rich fibrin (PRF)Active comparatorProcedure: Platelet rich fibrin (PRF)Platelet rich fibrin is the secoond generation of platelet concentrates which is an autogenous biomaterial that is prepared from the patient's own blood
Advanced platelet rich fibrin (A-PRF)ExperimentalProcedure: Advanced platelet rich fibrin (A-PRF)Advanced platelet rich fibrin is the last modification of PRF which is expected to contain a relatively greater number of white blood cellsand growth factors
blood clotPlacebo comparatorProcedure: blood clotnormal healing of the wound without adding any biomaterial
  • Platelet rich fibrin (PRF) (Procedure): following atraumatic extraction of the tooth using periotomes , 10 ml of patient's blood will be drawn by vein puncture of the antecubital vein and prepared in a centrifuge at 3000 rpm for 10 minutes then criss horizontal mattress suture will be applied to close the extraction wound
  • Advanced platelet rich fibrin (A-PRF) (Procedure): following atraumatic extraction of the tooth using periotomes , 10 ml of patient's blood will be drawn by vein puncture of the antecubital vein and prepared in a centrifuge at 1300 rpm for 8 minutes then criss horizontal mattress suture will be applied to close the extraction wound
  • blood clot (Procedure): following atraumatic extraction of the tooth using periotomes, no bio-addative will be added and criss horizontal mattress suture will be applied to close the extraction wound

+Outcome measures

Primary outcomes

  • Change in bucco-lingual dimensions [6 months]: clinical measurement using bone caliper in mm numerical

Secondary outcomes

  • change in alveolar bone height [6 months]: radiographic measurement using CBCT in mm numerical
  • bone dentistry [6 months]: radiographic measurement using CBCT
  • soft tissue healing [6 months]: clinical measurement using landr et al index (healing index) in numerical
  • postoperative pain scores [2 weeks]: clinical measurement using VAS scale in numerical where No pain (0-4 mm) - mild pain (5-44 mm) -moderate pain (45-74 mm), and severe pain (75- 100 mm).

+Eligibility

Sex: All, ages: 20 Years to 60 Years, accepts healthy volunteers

Inclusion Criteria:

* Patients with at least one non restorable tooth in upper inter-bicuspid region.
* Stable periodontal condition with no acute periapical infection.
* Systematically healthy conditions.
* Cooperative patients.
* Intact buccal plate of bone.

Exclusion Criteria:

* Smokers.
* Patients seeking immediate or early implants.
* Pregnant females.
* Bone diseases.
* Drugs and diseases that may affect platelet count or function.

+Locations (1)

FacilityCityCountryStatus
School of dentistry , Cairo UniversityCairoEgypt